Research / SYM / Fundamental state Inspectable configuration
State dimensions Filing 0001837240-23-000189 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.33% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.61% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
98.36% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
11.57% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
16.12% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-18.97% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
16.57% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
13.10% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Jun 25, 2022 0/4 normalized Level 3 Sep 24, 2022 0/7 normalized Level 3 Dec 24, 2022 0/7 normalized Level 3 Mar 25, 2023 0/7 normalized Level 3 Jun 24, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 30, 2023 0/8 normalized Level 3 Mar 30, 2024 0/8 normalized Level 3 Jun 29, 2024 4/8 normalized Level 3 Dec 30, 2023 0/8 normalized Amended as filed Mar 30, 2024 0/8 normalized Amended as filed Jun 29, 2024 4/8 normalized Amended as filed Sep 28, 2024 7/8 normalized Level 3 Dec 28, 2024 7/8 normalized Level 3 Mar 29, 2025 6/7 normalized Level 3 Jun 28, 2025 7/7 normalized Level 3 Sep 27, 2025 7/7 normalized Level 3 Dec 27, 2025 7/7 normalized Level 3 Mar 28, 2026 7/7 normalized Level 3 Jun 27, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 2.36%
Current 1.33%
Delta -1.03% Cash Generation Increased
Previous 17.29%
Current 19.61%
Delta 2.33% Growth Increased
Previous 77.63%
Current 98.36%
Delta 20.73% Inventory Pressure Decreased
Previous 53.51%
Current 11.57%
Delta -41.95% Margin Decreased
Previous 16.97%
Current 16.12%
Delta -0.84% Profitability Decreased
Previous -13.47%
Current -18.97%
Delta -5.50% R And D Intensity Increased
Previous 15.66%
Current 16.57%
Delta 0.91% Sbc Intensity Increased
Previous 11.86%
Current 13.10%
Delta 1.24% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.